Micranoic acid A is primarily investigated for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in suppressing pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory conditions. Studies suggest it may influence signaling pathways such as NF-κB, which plays a central role in inflammation and cell survival. Due to its biological activity, Micranoic acid A is used in preclinical research to explore new therapeutic approaches for diseases like rheumatoid arthritis, inflammatory bowel disease, and certain neurodegenerative disorders. Its natural origin and specific mechanism of action also make it a lead compound in the development of novel anti-inflammatory agents.